SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): August 14, 2002
GENESIS HEALTH VENTURES, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Pennsylvania 0-33217 06-1132947
------------ ------- ----------
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)
101 East State Street, Kennett Square, Pennsylvania 19348
---------------------------------------------------------
(Address of principal executive offices/Zip Code)
Registrant's telephone number, including area code: (610) 444-6350
Former name, former address, and former fiscal year, if changed since
last report: N/A
---
Item 7. FINANCIAL STATEMENT, PRO FORMA, FINANCIAL STATEMENTS AND EXHIBITS
C. Exhibits
99.1 Statement Under Oath of Robert H. Fish, Principal
Executive Officer, of Genesis Health Ventures, Inc. dated August 14,
2002 regarding Facts and Circumstances Relating to Securities Exchange
Act of 1934, as amended, Filings.
99.2 Statement Under Oath of George V. Hager, Jr., Principal
Financial Officer, of Genesis Health Ventures, Inc. dated August 14,
2002 regarding Facts and Circumstances Relating to Securities Exchange
Act of 1934, as amended, Filings.
99.3 Certificate of Robert H. Fish, Principal Executive
Officer, of Genesis Health Ventures, Inc. dated August 14, 2002
pursuant to 18 U.S.C. Section 1350.
99.4 Certificate of George V. Hager, Jr., Principal Financial
Officer, of Genesis Health Ventures, Inc. dated August 14, 2002
pursuant to 18 U.S.C. Section 1350.
Item 9. Regulation FD Disclosure.
On August 14, 2002, each of the Principal Executive Officer, Robert H.
Fish (the "Principal Executive Officer"), and the Principal Financial Officer,
George V. Hager, Jr. (the "Principal Financial Officer"), of Genesis Health
Ventures, Inc. (the "Company") submitted to the Securities and Exchange
Commission ("SEC") sworn statements pursuant to Section 21(a)(1) of the
Securities Exchange Act 1934, as amended (SEC Order No. 4-460, June 27, 2002). A
copy of each of these certifications is attached as an exhibit hereto.
On August 14, 2002, the Company also filed its quarterly report on Form
10-Q for the quarter ended June 30, 2002, with the SEC. Accompanying such report
were certifications of each of the Principal Executive Officer and the Principal
Financial Officer of the Company, submitted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350). A copy of each of these
certifications is attached as an exhibit hereto.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, GENESIS HEALTH VENTURES, INC., Inc. has duly caused this report to be
signed on its behalf by the undersigned hereunto duly authorized.
GENESIS HEALTH VENTURES, INC.
Date: August 14, 2002 By: /s/ George V. Hager, Jr.
-----------------------------
George V. Hager, Jr.
Executive Vice President and
Chief Financial Officer